Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24833244&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deep Brain Stimulation for Movement Disorders #MMPMID24833244
Larson PS
Neurotherapeutics 2014[Jul]; 11 (3): 465-74 PMID24833244show ga
Deep brain stimulation (DBS) is an implanted electrical device that modulates specific targets in the brain resulting in symptomatic improvement in a particular neurologic disease, most commonly a movement disorder. It is preferred over previously used lesioning procedures due to its reversibility, adjustability, and ability to be used bilaterally with a good safety profile. Risks of DBS include intracranial bleeding, infection, malposition, and hardware issues, such migration, disconnection, or malfunction, but the risk of each of these complications is low?generally ? 5% at experienced, large-volume centers. It has been used widely in essential tremor, Parkinson?s disease, and dystonia when medical treatment becomes ineffective, intolerable owing to side effects, or causes motor complications. Brain targets implanted include the thalamus (most commonly for essential tremor), subthalamic nucleus (most commonly for Parkinson?s disease), and globus pallidus (Parkinson?s disease and dystonia), although new targets are currently being explored. Future developments include brain electrodes that can steer current directionally and systems capable of ?closed loop? stimulation, with systems that can record and interpret regional brain activity and modify stimulation parameters in a clinically meaningful way. New, image-guided implantation techniques may have advantages over traditional DBS surgery.Electronic supplementary material: The online version of this article (doi:10.1007/s13311-014-0274-1) contains supplementary material, which is available to authorized users.
free
free
free
Neurotherapeutics 2014 ; 11 (3): 465-74
